| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |